These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
551 related articles for article (PubMed ID: 33805772)
1. Pre-Clinical Neuroprotective Evidences and Plausible Mechanisms of Sulforaphane in Alzheimer's Disease. Kim J Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33805772 [TBL] [Abstract][Full Text] [Related]
2. Sulforaphane Upregulates the Heat Shock Protein Co-Chaperone CHIP and Clears Amyloid-β and Tau in a Mouse Model of Alzheimer's Disease. Lee S; Choi BR; Kim J; LaFerla FM; Park JHY; Han JS; Lee KW; Kim J Mol Nutr Food Res; 2018 Jun; 62(12):e1800240. PubMed ID: 29714053 [TBL] [Abstract][Full Text] [Related]
3. Natural Dietary Supplementation of Anthocyanins via PI3K/Akt/Nrf2/HO-1 Pathways Mitigate Oxidative Stress, Neurodegeneration, and Memory Impairment in a Mouse Model of Alzheimer's Disease. Ali T; Kim T; Rehman SU; Khan MS; Amin FU; Khan M; Ikram M; Kim MO Mol Neurobiol; 2018 Jul; 55(7):6076-6093. PubMed ID: 29170981 [TBL] [Abstract][Full Text] [Related]
4. Molecular Insight into the Therapeutic Promise of Flavonoids against Alzheimer's Disease. Uddin MS; Kabir MT; Niaz K; Jeandet P; Clément C; Mathew B; Rauf A; Rengasamy KRR; Sobarzo-Sánchez E; Ashraf GM; Aleya L Molecules; 2020 Mar; 25(6):. PubMed ID: 32168835 [TBL] [Abstract][Full Text] [Related]
5. Epigenetic modification of Nrf2 by sulforaphane increases the antioxidative and anti-inflammatory capacity in a cellular model of Alzheimer's disease. Zhao F; Zhang J; Chang N Eur J Pharmacol; 2018 Apr; 824():1-10. PubMed ID: 29382536 [TBL] [Abstract][Full Text] [Related]
6. Sulforaphane ameliorates neurobehavioral deficits and protects the brain from amyloid β deposits and peroxidation in mice with Alzheimer-like lesions. Zhang R; Miao QW; Zhu CX; Zhao Y; Liu L; Yang J; An L Am J Alzheimers Dis Other Demen; 2015 Mar; 30(2):183-91. PubMed ID: 25024455 [TBL] [Abstract][Full Text] [Related]
7. Sulforaphane Inhibits the Generation of Amyloid-β Oligomer and Promotes Spatial Learning and Memory in Alzheimer's Disease (PS1V97L) Transgenic Mice. Hou TT; Yang HY; Wang W; Wu QQ; Tian YR; Jia JP J Alzheimers Dis; 2018; 62(4):1803-1813. PubMed ID: 29614663 [TBL] [Abstract][Full Text] [Related]
8. Neuroprotective Effects of Sulforaphane in a rat model of Alzheimer's Disease induced by Aβ (1-42) peptides. Khan WU; Salman M; Ali M; Majid H; Yar MS; Akhtar M; Parvez S; Najmi AK Neurochem Int; 2024 Oct; 179():105839. PubMed ID: 39173832 [TBL] [Abstract][Full Text] [Related]
9. Oral administration of methysticin improves cognitive deficits in a mouse model of Alzheimer's disease. Fragoulis A; Siegl S; Fendt M; Jansen S; Soppa U; Brandenburg LO; Pufe T; Weis J; Wruck CJ Redox Biol; 2017 Aug; 12():843-853. PubMed ID: 28448946 [TBL] [Abstract][Full Text] [Related]
10. Sulforaphane Ameliorates Okadaic Acid-Induced Memory Impairment in Rats by Activating the Nrf2/HO-1 Antioxidant Pathway. Dwivedi S; Rajasekar N; Hanif K; Nath C; Shukla R Mol Neurobiol; 2016 Oct; 53(8):5310-23. PubMed ID: 26433376 [TBL] [Abstract][Full Text] [Related]
11. Klotho upregulation contributes to the neuroprotection of ligustilide in an Alzheimer's disease mouse model. Kuang X; Chen YS; Wang LF; Li YJ; Liu K; Zhang MX; Li LJ; Chen C; He Q; Wang Y; Du JR Neurobiol Aging; 2014 Jan; 35(1):169-78. PubMed ID: 23973442 [TBL] [Abstract][Full Text] [Related]
12. Sulforaphane exerts its anti-inflammatory effect against amyloid-β peptide via STAT-1 dephosphorylation and activation of Nrf2/HO-1 cascade in human THP-1 macrophages. An YW; Jhang KA; Woo SY; Kang JL; Chong YH Neurobiol Aging; 2016 Feb; 38():1-10. PubMed ID: 26827637 [TBL] [Abstract][Full Text] [Related]
13. Molecular Pharmacology of Rosmarinic and Salvianolic Acids: Potential Seeds for Alzheimer's and Vascular Dementia Drugs. Habtemariam S Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29401682 [TBL] [Abstract][Full Text] [Related]
14. Ca2+-permeable TRPV1 pain receptor knockout rescues memory deficits and reduces amyloid-β and tau in a mouse model of Alzheimer's disease. Kim J; Lee S; Kim J; Ham S; Park JHY; Han S; Jung YK; Shim I; Han JS; Lee KW; Kim J Hum Mol Genet; 2020 Jan; 29(2):228-237. PubMed ID: 31814000 [TBL] [Abstract][Full Text] [Related]
15. Are N- and C-terminally truncated Aβ species key pathological triggers in Alzheimer's disease? Dunys J; Valverde A; Checler F J Biol Chem; 2018 Oct; 293(40):15419-15428. PubMed ID: 30143530 [TBL] [Abstract][Full Text] [Related]
16. Mitochondrial Calcium Deregulation in the Mechanism of Beta-Amyloid and Tau Pathology. Esteras N; Abramov AY Cells; 2020 Sep; 9(9):. PubMed ID: 32967303 [TBL] [Abstract][Full Text] [Related]
17. Ebselen ameliorates β-amyloid pathology, tau pathology, and cognitive impairment in triple-transgenic Alzheimer's disease mice. Xie Y; Tan Y; Zheng Y; Du X; Liu Q J Biol Inorg Chem; 2017 Aug; 22(6):851-865. PubMed ID: 28502066 [TBL] [Abstract][Full Text] [Related]
18. SLOH, a carbazole-based fluorophore, mitigates neuropathology and behavioral impairment in the triple-transgenic mouse model of Alzheimer's disease. Wu X; Kosaraju J; Zhou W; Tam KY Neuropharmacology; 2018 Mar; 131():351-363. PubMed ID: 29309769 [TBL] [Abstract][Full Text] [Related]
19. An Increasing Role of Polyphenols as Novel Therapeutics for Alzheimer's: A Review. Karim N; Khan H; Khan I; Guo O; Sobarzo-Sánchez E; Rastrelli L; Kamal MA Med Chem; 2020; 16(8):1007-1021. PubMed ID: 31702507 [TBL] [Abstract][Full Text] [Related]
20. Sulforaphane inhibits the production of Aβ partially through the activation of Nrf2-regulated oxidative stress. Zhang S; Zhao J; Bai Z; Luo L; Wu F; Li B; Shan Y Food Funct; 2021 Nov; 12(22):11482-11490. PubMed ID: 34699582 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]